VOR

Latest SEC Filings & News for VOR

2 most recent filings and news items mentioning VOR. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/VOR/news?limit=20"

Pull VOR filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
OtherJun 12, 2026Positive

Vor Biopharma amends and restates 2021 equity incentive plan with expanded share reserve.

Vor Biopharma's board adopted and stockholders approved an amended and restated 2021 Equity Incentive Plan on June 11, 2026, increasing the share reserve to 2.3 million shares plus annual 4% increases through 2035. The expanded plan enhances the company's ability to attract and r

View filing at SEC.gov →
RegulatoryJun 8, 2026Positive

Vor Bio's telitacicept receives NMPA conditional approval for IgA nephropathy in China

China's NMPA conditionally approved telitacicept for IgA nephropathy, marking the first BAFF/APRIL-targeting therapy approved for this indication and the fourth approval for the drug. The approval, based on positive Phase 3 TELIGAN results, validates the dual mechanism and suppor

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.